Literature DB >> 29657244

Infiltration characteristics and influencing factors of retroperitoneal liposarcoma: Novel evidence for extended surgery and a tumor grading system.

Zhen Wang1, Jianhui Wu1, Ang Lv1, Chengpeng Li1, Zhongwu Li2, Min Zhao2, Chunyi Hao1.   

Abstract

This study sought to evaluate the infiltration tendency of retroperitoneal liposarcoma (RPLS) from a new pathological angle by exploring the infiltration characteristics, which could provide helpful information to facilitate surgical decision-making and prognosis prediction. Concurrently, we aim to identify significant indicators of infiltration. A total of 61 consecutive patients with RPLS at our institution were retrospectively analyzed. All patients received extended surgery. The tumor infiltration characteristics and influencing factors were studied based on the pathological diagnosis. Univariate and multivariate analyses of organ infiltration (OI) and surrounding fat infiltration (SFI) were performed. OI was found in 95 (28.5%) resected organs from 39 (60.7%) patients, and SFI was found in 119 (35.7%) resected organs from 47 (77%) patients. The tumor infiltrated the serosal layer of 13 organs (13/37, 35.1%), the muscularis layer of 18 organs (18/37, 48.6%) and the submucosa of 6 organs (6/37, 16.2%). The percentage of lipoblasts and the rates of necrosis and mitosis were all significantly higher in high-grade tumors (dedifferentiated, round cell, and pleomorphic). A high lipoblast percentage (≥ 20%) was the only independent risk factor for OI. A recurrent tumor and a high-grade tumor were independent risk factors for SFI. In conclusion, RPLS has a high infiltration tendency, such that it frequently infiltrates organs and surrounding fat tissue. Therefore, extended resection of the tumor and the adjacent organs is recommended. The percentage of lipoblasts was associated with the tumor grade and infiltration characteristics; thus, lipoblast percentage may become a new grading factor for RPLS.

Entities:  

Keywords:  Retroperitoneal sarcoma; infiltration; liposarcoma

Mesh:

Year:  2018        PMID: 29657244     DOI: 10.5582/bst.2018.01015

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  6 in total

Review 1.  [Retroperitoneal soft tissue sarcoma: surgical management].

Authors:  Franziska Willis; Martin Schneider
Journal:  Chirurg       Date:  2021-10-01       Impact factor: 0.955

Review 2.  Retroperitoneal Sarcomas: a Current Review on Management.

Authors:  Shraddha Patkar; Abhay K Kattepur; Nehal Khanna; Jyoti Bajpai
Journal:  Indian J Surg Oncol       Date:  2022-02-21

3.  Pancreaticoduodenectomy for Retroperitoneal Sarcomas: A Mono-Institutional Experience in China.

Authors:  Cheng-Peng Li; Zhen Wang; Bo-Nan Liu; Ang Lv; Dao-Ning Liu; Jian-Hui Wu; Hui Qiu; Chun-Yi Hao
Journal:  Front Oncol       Date:  2020-09-23       Impact factor: 6.244

4.  A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study.

Authors:  Cheng-Li Miao; Ling-Ling Zhang; William W Tseng; Fa-Bo Qiu; Wei-Qi Lu; You-Guo Dai; Xiao-Song Rao; Wen-Jie Li; Gao-Kui Zhang; Jun Chen; Wen-Qing Liu; Xiao-Bing Chen; Meng-Meng Xiao; Li-Chao Cha; Jiong-Yuan Wang; Yu-Bo Ren; Hao-Yun Yang; Cheng-Hua Luo
Journal:  Ann Transl Med       Date:  2022-07

5.  Patients with first recurrent retroperitoneal sarcoma that can be macroscopically completely resected can achieve comparable outcomes with that of primary patients after en bloc resection of tumor and adjacent organs.

Authors:  Zhen Wang; Jian-Hui Wu; Cheng-Peng Li; Ang Lv; Hui Qiu; Xiu-Yun Tian; Bo-Nan Liu; Chun-Yi Hao
Journal:  Front Surg       Date:  2022-09-07

6.  Surgical Diagnosis and Treatment of Primary Retroperitoneal Liposarcoma.

Authors:  Jie Chen; Ying Hang; Qi Gao; Xinyu Huang
Journal:  Front Surg       Date:  2021-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.